Gene: ST7L
Official Full Name: suppression of tumorigenicity 7 likeprovided by HGNC
Gene Summary: This gene was identified by its similarity to the ST7 tumor suppressor gene found in the chromosome 7q31 region. This gene is clustered in a tail-to-tail manner with the WNT2B gene in a chromosomal region known to be deleted and rearranged in a variety of cancers. Several transcript variants encoding many different isoforms have been described, but some have not been fully characterized. [provided by RefSeq, Feb 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13710 | ST7L Knockout cell line (HeLa) | Human | ST7L | 1:3~1:6 | Negative | Online Inquiry |
KO13711 | ST7L Knockout cell line (HCT 116) | Human | ST7L | 1:2~1:4 | Negative | Online Inquiry |
KO13712 | ST7L Knockout cell line (HEK293) | Human | ST7L | 1:3~1:6 | Negative | Online Inquiry |
KO13713 | ST7L Knockout cell line (A549) | Human | ST7L | 1:3~1:4 | Negative | Online Inquiry |
ST7L Gene Knockout Cell Lines are a cutting-edge tool in molecular biology designed for investigating the functional role of the ST7L gene, which is implicated in various biological processes and disease mechanisms. These cell lines are engineered using advanced CRISPR/Cas9 technology, resulting in targeted disruption of the ST7L gene, allowing researchers to establish a clear connection between gene function and cellular behavior.
The key function of ST7L Gene Knockout Cell Lines lies in their ability to facilitate gene function studies, signaling pathway exploration, and drug discovery processes. By knocking out the ST7L gene, scientists can measure subsequent changes in cellular processes such as proliferation, apoptosis, and differentiation. The resulting phenotypic variations serve as a platform for elucidating the gene's role within the broader context of cellular signaling networks and disease states.
In the realm of scientific research and clinical applications, these cell lines are invaluable for investigating the molecular underpinnings of diseases such as cancer and neurological disorders. They provide a robust model for screening therapeutic compounds and understanding the mechanisms by which ST7L may influence disease progression, thereby promoting the development of targeted therapies.
Compared to alternative cell lines that do not specifically manipulate the ST7L gene, our knockout models offer precision and specificity in gene manipulation. Researchers can derive reproducible and meaningful results more effectively, significantly reducing the ambiguity often associated with studies using traditional wild-type cell lines.
The ST7L Gene Knockout Cell Lines are particularly appealing to both researchers and clinicians seeking innovative solutions for understanding gene function in a controlled environment. They represent a critical advancement in the toolkit for modern biology, enabling heightened accuracy in experimental design and the generation of actionable insights into complex disease scenarios.
Our company prides itself on its commitment to excellence in biological products, ensuring that our offerings are not only scientifically rigorous but also tailored to meet the evolving needs of the scientific community. With a team of experienced researchers and industry experts, we continue to drive advancements in genetic research tools, fostering innovation and collaboration to accelerate discovery in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.